MoonLake: Sonelokimab Phase 3 Week 40 Shows 62% Response: MoonLake reports 62% Week 40 clinical response for sonelokimab in Phase 3 VELA trials (Mar 28, 2026); full safety and endpoint details pending. 👈 Read full analysis #MoonLake #Sonelokimab #ClinicalTrials #Phase3 #AADMeeting
Sanofi Reports Positive Phase 3 Atopic Dermatitis Data: Sanofi said on Mar 28, 2026 its Phase 3 (n≈1,250) met the primary endpoint with ~64% achieving EASI-75 vs 18% placebo at Week 16 (Investing.com); full data pending. 👈 Read full analysis #Sanofi #AtopicDermatitis #Phase3 #ClinicalTrials #EASI75
#AstraZeneca's IL-33-targeting antibody #tozorakimab has made the grade in two #phase3 chronic obstructive pulmonary disease (#COPD) trials, raising the prospects of a class that has recorded some notable failures in the past.
THIS SUNDAY at Toejam ❤️🔥 Steve Angello & friends 🔊 use promo code BASTET during checkout to save! 🤑
🎟️ linktr.ee/BastetPromot... 🎟️
#BastetPromotions #SteveAngello #ToeJamMiami #MMW #MMW26 #MiamiMusicWeek #ToeJamXL #Phase3 #EDM #EDMBsky
🚨 Latest #Phase3 Update!
🔷 A Phase 3 trial evaluated adjuvant Atezolizumab plus mFOLFOX6 in patients with resected stage III dMMR colon cancer, compared with mFOLFOX6 alone. The study assessed whether adding immunotherapy could enhance disease-free survival (DFS) outcomes.
Abivax Prices Patience for June Phase‑3 Readout: Abivax says its June 2026 Phase‑3 maintenance readout could secure higher partnership terms; CEO comments were published Mar 24, 2026 (CNBC). 👈 Read full analysis #Abivax #Phase3 #ClinicalTrials #Biotech #DrugDevelopment
🚨 Latest #Phase3 Update!
🔷 Vergent Bioscience has initiated the Phase 3 VISUALIZE 2 trial evaluating Abenacianine (VGT-309) for real-time tumor visualization during lung cancer surgery, aiming to improve intraoperative detection and identification of malignant tissue.
🚨 Latest #Phase3 Update!
🔷 An international phase III randomized trial, EURO EWING 2012 (EE2012), evaluated adding zoledronic acid to consolidation chemotherapy in patients with Ewing sarcoma. The study examined whether bone-targeted therapy could improve clinical outcomes.
🚨 Latest #Phase3 Update!
🔷 In the phase 3 COMPASSION-16 trial, adding Cadonilimab to first-line chemotherapy (with or without Bevacizumab) delivered consistent progression-free survival (PFS) benefit across all tested subgroups, with a median follow-up of 25.6 months.
🚨 Latest #Phase3 Update!
🔷 In the Phase III LEAP-010 trial, lenvatinib + pembrolizumab improved PFS (6.2 vs 2.8 months; HR 0.64) and ORR (46.1% vs 25.4%) versus pembrolizumab alone in first-line PD-L1 CPS ≥1 R/M HNSCC.
🚨 Latest #Phase3 Update!
🔷 In a Phase III randomized trial (RECITE), Romiplostim significantly reduced chemotherapy dose modifications due to chemotherapy-induced thrombocytopenia (CIT) in patients receiving oxaliplatin-based chemotherapy for gastrointestinal cancers.
🚨 Latest #Phase3 Trial Update!
🔷 The Phase III CAMPASS trial evaluates benmelstobart plus anlotinib versus pembrolizumab as first-line therapy in patients with PD-L1–positive advanced NSCLC.
🧬 Deramiocel is back under #FDA review for #DMD cardiomyopathy.
The agency lifted a prior CRL and set a new PDUFA date of August 22, 2026, continuing evaluation of Capricor’s cell therapy following new #Phase3 HOPE-3 data.
Visit the NeurologyLive website to read more‼️
#Neurology #MDAconference
🚨 Latest #Phase3 Trial Update!
🔷 Bristol Myers Squibb’s Phase 3 SUCCESSOR-2 trial reports positive outcomes with oral Mezigdomide in relapsed or refractory multiple myeloma.
🚨 Latest #Phase3 Update!
🔷 A biomarker analysis from the Phase III CONTINUUM and DIPPER trials developed a machine-learning classifier identifying three metabolic subtypes (MS1–MS3) in locoregionally advanced nasopharyngeal carcinoma (NPC) to better predict response to immunotherapy.
#Roche's oral BTK inhibitor #fenebrutinib has hit the spot in the final trial in its #phase3 programme, in relapsing #multiplesclerosis (RMS), and is now being prepared for #regulatory filings.
pharmaphorum.com/news/after-p...
🚨 Latest #Phase3 Trial Update!
🔷 Adjuvant treatment with KEYTRUDA® (pembrolizumab) plus WELIREG® (belzutifan) reduced the risk of disease recurrence or death by 28% compared to KEYTRUDA® alone in certain patients with earlier-stage Renal cell carcinoma (RCC).
🚨 Latest #Phase3 Trial Update!
🔷 SystImmune and Bristol Myers Squibb highlight Phase III interim topline results show promising efficacy for izalontamab brengitecan (Iza-bren) in previously treated unresectable or metastatic triple-negative breast cancer.
🚨 Latest #Phase3 Trial Update!
🔷 Bayer’s PEACE-3 trial demonstrates a significant overall survival (OS) benefit with radium-223 dichloride plus enzalutamide in patients with metastatic castration-resistant prostate cancer and bone metastases.
Phase 3️⃣ NEAT: EryDex missed its primary endpoint in ataxia-telangiectasia.
🧠 RmICARS change did not reach significance (P=.0851), and no CGI-S benefit was seen—though tolerability appeared favorable. Visit our website for more!
#ClinicalTrials #RareDisease #Neurology #Phase3
Starting at about 2:30pm (pacific), I'll be playing #Satisfactory having just started #Phase3!
▶ YouTube: youtube.com/@artgh0sts
▶ Twitch: twitch.tv/artgh0sts
Bayer to present new Phase III data for the investigational low-dose MRI contrast agent gadoquatrane at ECR 2026, featuring a 60% reduction in gadolinium dose.
stellanews.life/technology/8...
#MRI #Radiology #Bayer #ECR2026 #Gadoquatrane #Phase3 #MedicalImaging #ContrastAgent
#Lundbeck #phase3 #migraineprevention #migrainepreventiondrug #bocunebart #antiPACAPantibody #phase2b #PROCEEDtrial #intravenousbocunebart #LuAG09222 #monthlymigrainedays #MMD #PACAP #neuropeptide #pathophysiologyofmigraine #migrainetreatment #PACAPpathway #migrainepreventionmarket
zurl.co/M7FHE
Astellas reports positive Phase 3 STARLIGHT 2 results in Japan for fezolinetant in vasomotor symptoms
stellanews.life/technology/8...
#Menopause #VMS #Fezolinetant #Phase3 #Astellas
UCB showcases three-year hidradenitis suppurativa data at EHSF; BIMZELX (bimekizumab) achieved inflammatory lesion resolution and substantial disease severity improvements
stellanews.life/technology/8...
#HidradenitisSuppurativa #HS #Bimekizumab #BIMZELX #EHSF #Phase3
リジェネロン、AAAAI 2026で免疫領域36演題発表へ
Regeneron Highlights Expanding Immunology Portfolio and Pipeline at AAAAI 2026
stellanews.life/technology/8...
AI impact rating（reference only）: ★★★★☆
This is an experimental indicator and not a guarantee of accuracy.
#AAAAI #Allergy #Dupilumab #Phase3 #Regeneron
Wondering where we’ve been? It may seem like we are hiding, but we’re still here in the vocal isolation booth 🎙️ getting ready for phase 3 of The Flip Phones. Watch this space for exciting news coming soon! 🔥 🎸 🎹 #theflipphones #newyear #phase3 #anticipation
Altimmune raises $75 million to advance pemvidutide, a promising therapy tackling serious liver and metabolic diseases.
longevity.technology/news/altimmu...
#longevity #liverhealth #biotechfunding #phase3 #metabolichealth #clinicaltrials
Bizarrap en el #Ultra de Miami, ¿pero qué mierda es esta? 🤮 #UMF #Ultra26 #UltraMiami #UMF2026 #BZRP #Bizarrap #Ultra2026 #UltraMiami2026 #Miami #Phase3 #BayFrontPark
